612 related articles for article (PubMed ID: 19394731)
1. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
[TBL] [Abstract][Full Text] [Related]
2. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
Solomon LR; Cheesbrough JS; Ebah L; Al-Sayed T; Heap M; Millband N; Waterhouse D; Mitra S; Curry A; Saxena R; Bhat R; Schulz M; Diggle P
Am J Kidney Dis; 2010 Jun; 55(6):1060-8. PubMed ID: 20207458
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
[TBL] [Abstract][Full Text] [Related]
4. Prevention of tunneled cuffed hemodialysis catheter-related dysfunction and bacteremia by a neutral-valve closed-system connector: a single-center randomized controlled trial.
Bonkain F; Racapé J; Goncalvez I; Moerman M; Denis O; Gammar N; Gastaldello K; Nortier JL
Am J Kidney Dis; 2013 Mar; 61(3):459-65. PubMed ID: 23228946
[TBL] [Abstract][Full Text] [Related]
5. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
[TBL] [Abstract][Full Text] [Related]
6. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial.
Kanaa M; Wright MJ; Akbani H; Laboi P; Bhandari S; Sandoe JA
Am J Kidney Dis; 2015 Dec; 66(6):1015-23. PubMed ID: 26141306
[TBL] [Abstract][Full Text] [Related]
7. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study.
Saxena AK; Panhotra BR
J Nephrol; 2005; 18(6):755-63. PubMed ID: 16358235
[TBL] [Abstract][Full Text] [Related]
8. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.
Weijmer MC; van den Dorpel MA; Van de Ven PJ; ter Wee PM; van Geelen JA; Groeneveld JO; van Jaarsveld BC; Koopmans MG; le Poole CY; Schrander-Van der Meer AM; Siegert CE; Stas KJ;
J Am Soc Nephrol; 2005 Sep; 16(9):2769-77. PubMed ID: 16033861
[TBL] [Abstract][Full Text] [Related]
9. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
Yon CK; Low CL
Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
[TBL] [Abstract][Full Text] [Related]
10. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial.
Maki DG; Ash SR; Winger RK; Lavin P;
Crit Care Med; 2011 Apr; 39(4):613-20. PubMed ID: 21200319
[TBL] [Abstract][Full Text] [Related]
11. Concentrated Sodium Citrate (23%) for Catheter Lock.
Ash SR; Mankus RA; Sutton JM; Criswell RE; Crull CC; Velasquez KA; Smeltzer BD; Ing TS
Hemodial Int; 2000 Jan; 4(1):22-31. PubMed ID: 28455911
[TBL] [Abstract][Full Text] [Related]
12. Temporary hemodialysis catheters as a long-term vascular access in chronic hemodialysis patients.
Ponikvar R; Buturović-Ponikvar J
Ther Apher Dial; 2005 Jun; 9(3):250-3. PubMed ID: 15967000
[TBL] [Abstract][Full Text] [Related]
13. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
Bruyère R; Soudry-Faure A; Capellier G; Binquet C; Nadji A; Torner S; Blasco G; Yannaraki M; Barbar SD; Quenot JP
Trials; 2014 Nov; 15():449. PubMed ID: 25409678
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized, double-blind crossover study on the use of 5% citrate lock versus 10% citrate lock in permanent hemodialysis catheters.
Meeus G; Kuypers DR; Claes K; Evenepoel P; Maes B; Vanrenterghem Y
Blood Purif; 2005; 23(2):101-5. PubMed ID: 15640601
[TBL] [Abstract][Full Text] [Related]
15. Catheter-related bacteremia in hemodialysis: which preventive measures to take?
Silva J; Teixeira e Costa ; Baptista A; Ramos A; Ponce P
Nephron Clin Pract; 2008; 110(4):c251-7. PubMed ID: 18974657
[TBL] [Abstract][Full Text] [Related]
16. Locking tunneled hemodialysis catheters with hypertonic saline (26% NaCl) and heparin to prevent catheter-related bloodstream infections and thrombosis: a randomized, prospective trial.
Oguzhan N; Pala C; Sipahioglu MH; Cilan H; Durmaz S; Percin D; Unal A; Tokgoz B; Utas C; Oymak O
Ren Fail; 2012; 34(2):181-8. PubMed ID: 22260745
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of preventing hemodialysis catheter infections with citrate lock.
Silva J; Antunes J; Carvalho T; Ponce P
Hemodial Int; 2012 Oct; 16(4):545-52. PubMed ID: 22515732
[TBL] [Abstract][Full Text] [Related]
18. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
[TBL] [Abstract][Full Text] [Related]
19. An ethanol/sodium citrate locking solution compared to heparin to prevent hemodialysis catheter-related infections: a randomized pilot study.
Vercaigne LM; Allan DR; Armstrong SW; Zacharias JM; Miller LM
J Vasc Access; 2016; 17(1):55-62. PubMed ID: 26660041
[TBL] [Abstract][Full Text] [Related]
20. Sodium citrate versus saline catheter locks for non-tunneled hemodialysis central venous catheters in critically ill adults: a randomized controlled trial.
Hermite L; Quenot JP; Nadji A; Barbar SD; Charles PE; Hamet M; Jacquiot N; Ghiringhelli F; Freysz M
Intensive Care Med; 2012 Feb; 38(2):279-85. PubMed ID: 22124771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
